Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Assaad Semaan"'
Autor:
Sanjeev Kumar, Sudeshna Bandyopadhyay, Assaad Semaan, Jay P Shah, Haider Mahdi, Robert Morris, Adnan Munkarah, Rouba Ali-Fehmi
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e21912 (2011)
BACKGROUND: The role of frozen section (FS) in intraoperative decision making for surgical staging of endometrial cancer is controversial. Objective of this study is to assess the agreement rate between the FS and paraffin section (PS); and the poten
Externí odkaz:
https://doaj.org/article/fc478078b65d432b9052467437ef02f0
Publikováno v:
Pharmacogenetics and genomics. 27(7)
Background Alterations in nuclear pore complex (NPC) genes have been previously associated with response to chemotherapy. Using agnostic exome sequencing, we envisioned that new alleles in NPC genes, predictive of sensitivity to platinum treatment, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30ec6050b8aa5f4c5174acbbe53f75fa
https://pubmed.ncbi.nlm.nih.gov/28562428
https://pubmed.ncbi.nlm.nih.gov/28562428
Autor:
Shelly Seward, Sreedhar Chamala, David L. Bouwman, Assaad Semaan, Donald W. Weaver, Aamer Qazi, Ramesh B. Batchu, Scott A. Gruber, Oksana V. Gruzdyn, Vasu B. Dhulipala
Publikováno v:
Surgery. 154:739-747
Purpose Enhancer of zeste homologue 2 (EZH2), a component of the chromatin modification protein complex, is upregulated in pancreatic ductal adenocarcinoma (PDAC), whereas loss of p53 and its downstream target, p21 waf1/cip1 , is also observed freque
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c5e244d0adab1157c4604a77bb29ede
https://doi.org/10.1016/j.surg.2013.06.041
https://doi.org/10.1016/j.surg.2013.06.041
Autor:
Donald W. Weaver, Seema Sethi, David L. Bouwman, Robert T. Morris, Shelly Seward, Aamer Qazi, Assaad Semaan, Sreedhar Chamala, Ramesh B. Batchu, Scott A. Gruber, David Cameron, Rouba Ali-Fehmi, Oksana V. Gruzdyn, Adnan R. Munkarah, Sanjeev Kumar, Christopher C. Bryant
Publikováno v:
Cancer Letters. 336:53-60
The enhancer of zeste homolog 2 (EZH2) methyltransferase is a transcriptional repressor. EZH2 is abnormally elevated in epithelial ovarian cancer (EOC). We demonstrated that EZH2 knockdown inhibited cell growth, activated apoptosis, and enhanced chem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9d96207c8fb71af6eb43e5fa2c96d7c
https://doi.org/10.1016/j.canlet.2013.04.012
https://doi.org/10.1016/j.canlet.2013.04.012
Publikováno v:
International Journal of Gynecological Cancer. 23:1118-1126
We aimed to compare the differences in demographic features, clinicopathologic features, and survival in patients with vulvar/vaginal melanoma versus cutaneous melanoma with a special emphasis on race.Data were obtained from the Surveillance Epidemio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86c86245b7aaf4eaef8335ebbadbec49
https://doi.org/10.1097/igc.0b013e3182980ffb
https://doi.org/10.1097/igc.0b013e3182980ffb
Autor:
Baraa Alosh, Adnan R. Munkarah, Assaad Semaan, Anil K. Sood, Rouba Ali-Fehmi, Kinda Hayek, Jun Zhou, Zhengming Chen, Tarek Jazaerly, Yaser R. Hussein, Ju Won Roh, Sudeshna Bandyopadhyay
Publikováno v:
Gynecologic Oncology. 128:344-348
The deregulation of E-cadherin is associated with Src/FAK signaling axis and histone deacetylase (HDAC)/EZH2 activity. However, the association between EZH2 and FAK and its clinical significance in endometrial carcinoma has not been reported.202 arch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93652349d75a5c88eaa9a70b81fedf86
https://doi.org/10.1016/j.ygyno.2012.07.128
https://doi.org/10.1016/j.ygyno.2012.07.128
Autor:
Fadi W. Abdul-Karim, Kinda Hayek, Richard Morris, Baraa Alosh, Adnan R. Munkarah, D. Schulz, Assaad Semaan, Haider Mahdi, Michele L. Cote, Faisal Qureshi, Esther Oliva, Marisa R. Nucci, K. K. Van de Vijver, Sudeshna Bandyopadhyay, Rouba Ali-Fehmi, Ira Winer, Yaser R. Hussein
Publikováno v:
Gynecologic Oncology, 128(2), 316-321. Elsevier Science
Uterine serous carcinoma (USC) constitutes 10% of uterine cancers but ~40% of deaths. Tumor size is a known prognostic factor in other solid tumors. In endometriod cancers it is one element used to identify the need for complete staging, while its si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77d1e75c2f25ce5aeaf74d95d822fe90
https://doi.org/10.1016/j.ygyno.2012.10.027
https://doi.org/10.1016/j.ygyno.2012.10.027
Autor:
Z. Al-Wahab, Robert T. Morris, Shelly Seward, Michele L. Cote, Adnan R. Munkarah, Rouba Ali-Fehmi, Sudeshna Bandyopadhyay, Mohamed A. Elshaikh, Assaad Semaan
Publikováno v:
International Journal of Gynecologic Cancer. 22:452-456
ObjectiveOur aim was to evaluate the prognostic significance of the revised 2009 International Federation of Gynecology and Obstetrics (FIGO) staging criteria in patients with uterine serous carcinoma (USC).Materials and MethodsWe retrieved clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7af7350c15f7818e238540307726834a
https://doi.org/10.1097/igc.0b013e31823de6dd
https://doi.org/10.1097/igc.0b013e31823de6dd
Autor:
Agnieszka Vay, Adnan R. Munkarah, Assaad Semaan, Sanjeev Kumar, Charles A. Schiffer, Robert T. Morris, Shelly Seward
Publikováno v:
Gynecologic Oncology. 123:456-460
Therapy related acute myeloid leukemia (t-AML) is a potential late complication of cytotoxic therapy, and it is of particular concern in the treatment of patients with epithelial ovarian carcinoma (EOC) exposed to multiple courses of chemotherapy dur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e0a736da963302c774dea4f74d3a03f
https://doi.org/10.1016/j.ygyno.2011.07.097
https://doi.org/10.1016/j.ygyno.2011.07.097
Autor:
Sudeshna Bandyopadhyay, Quratulain Ahmed, Rouba Ali-Fehmi, Bassam Albashiti, Yaser R. Hussein, Assaad Semaan, Zeina Nahleh, Tarek Jazaerly
Publikováno v:
Translational Oncology. 4(6):321-327
INTRODUCTION: Glucose transporter 1 (Glut-1) is a facilitative glucose transporter expressed in many cancers including breast cancer. Basal-like breast cancer (BLBC) is a high-risk disease associated with poor prognosis and lacks the benefit of targe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2401c0085708f39d1204b8dfb4a81a8b